本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cytokinetics

73.77
+0.15000.20%
盤後73.770.00000.00%19:30 EDT
成交量:172.15萬
成交額:1.28億
市值:102.56億
市盈率:-10.27
高:75.98
開:74.66
低:73.50
收:73.62
52周最高:88.31
52周最低:47.22
股本:1.39億
流通股本:1.38億
量比:1.14
換手率:1.25%
股息:- -
股息率:- -
每股收益(TTM):-7.1827
每股收益(LYR):-6.5400
淨資產收益率:-572.15%
總資產收益率:-28.09%
市淨率:-59.12
市盈率(LYR):-11.28

資料載入中...

2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/17

重要事件披露

Form 8-K - Current report
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities